NutriBand (NTRB) Non Operating Interest Expenses (2018 - 2026)
NutriBand's (NTRB) quarterly Non Operating Interest Expenses came in at $4874.0 in Q3 2026, down 15.57% year-over-year from $5773.0 in Q3 2025, and down 2.68% quarter-over-quarter from $5008.0 in Q2 2026.
Analysis
NutriBand (NTRB) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends
NutriBand has disclosed Non Operating Interest Expenses across 9 years of filings, most recently posting $4874.0 for Q3 2026.
- In Q3 2026, Non Operating Interest Expenses fell 15.57% year-over-year to $4874.0; the TTM figure through Jul 2026 stood at $20764.0 (up 6.9% YoY), while the FY2026 annual figure was $22535.0, up 5.27% from the prior year.
- Non Operating Interest Expenses came in at $4874.0 for Q3 2026 at NutriBand, down from $5008.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $40200.0 in Q4 2023 to a low of -$109906.0 in Q1 2023.
- Average Non Operating Interest Expenses over 5 years is $3354.5, with a median of $5019.0 recorded in 2024.
- The largest YoY upside for Non Operating Interest Expenses was 913.62% in 2023 against a maximum downside of 3585.76% in 2023.
- Over 5 years, Non Operating Interest Expenses stood at $3966.0 in 2022, then jumped by 913.62% to $40200.0 in 2023, then tumbled by 89.97% to $4031.0 in 2024, then soared by 37.63% to $5548.0 in 2025, then decreased by 12.15% to $4874.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $4874.0 in Q3 2026, $5008.0 in Q2 2026, and $5334.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 120.70 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -13.26 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 396.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -41.02 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 6.66 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 3,000.00 |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 4,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 4,874.00 |
| Apr 30, 2026 | 5,008.00 |
| Jan 31, 2026 | 5,334.00 |
| Oct 31, 2025 | 5,548.00 |
| Jul 31, 2025 | 5,773.00 |
| Apr 30, 2025 | 5,880.00 |
| Jan 31, 2025 | 3,739.00 |
| Oct 31, 2024 | 4,031.00 |
| Jul 31, 2024 | 5,019.00 |
| Apr 30, 2024 | 8,618.00 |
| Jan 31, 2024 | 23,214.00 |
| Oct 31, 2023 | 40,200.00 |
| Jul 31, 2023 | 9,235.00 |
| Apr 30, 2023 | 3,166.00 |
| Jan 31, 2023 | -109,906.00 |
| Oct 31, 2022 | 3,966.00 |
| Jul 31, 2022 | 4,429.00 |
| Apr 30, 2022 | 32,454.00 |
| Jan 31, 2022 | 3,153.00 |
| Oct 31, 2021 | 33,380.00 |